Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database-Reference-Cited by-同舟云学术

Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database

Published:2016-06-21 Issue:1 Volume:2 Page:
ISSN:2055-0294
Container-title:Journal of Pharmaceutical Health Care and Sciences
language:en
Short-container-title:J Pharm Health Care Sci

Author:

Abe Junko,Umetsu Ryogo,Mataki Kanako,Kato Yamato,Ueda Natsumi,Nakayama Yoko,Hane Yuuki,Matsui Toshinobu,Hatahira Haruna,Sasaoka Sayaka,Motooka Yumi,Hara Hideaki,Kato Zenichiro,Kinosada Yasutomi,Inagaki Naoki,Nakamura Mitsuhiro

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology (nursing)

Link

http://link.springer.com/content/pdf/10.1186/s40780-016-0048-5

Reference26 articles.

1. Mockenhaupt M, Schöpf E. Epidemiology of drug-induced severe skin reactions. Semin Cutan Med Surg. 1996;15:236–43.

2. Rosen AC, Balagula Y, Raisch DW, Garg V, Nardone B, Larsen N, et al. Life-threatening dermatologic adverse events in oncology. Anticancer Drugs. 2014;25:225–34.

3. French LE, Trent JT, Kerdel FA. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol. 2006;6:543–9.

4. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault-Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225–30.

5. Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int. 2007;56:419–25.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database;Frontiers in Pharmacology;2024-09-02

2. Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis;Pharmaceuticals;2024-08-05

3. Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS;Biomedicines;2024-08-01

4. Cytokine release syndrome associated with immune checkpoint inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS;Expert Opinion on Drug Safety;2024-07-29

5. Economic Evaluation of HLA-B*15:02 Genotyping for Asian Australian Patients With Epilepsy;JAMA Dermatology;2024-06-01